To safely and effectively treat an arrhythmia, physicians benefit from understanding and localizing its source.Vektor Medical, Inc. has developed a non-invasive arrhythmia mapping technology, called vMap™, which uses advanced computational modeling and the patient’s electrocardiogram.
In a matter of minutes, vMap™ is designed to provide 2D and 3D information that the physician can consider, evaluate, and potentially use for treatment.
There are four main steps, designed specifically for the clinical workflow.
Collect a standard 12-lead ECG of the patient’s arrhythmia episode.
Analyze the ECG in the Vektor system by selecting the sections of the ECG with the arrhythmia.
Visualize results from patient’s ECG.
vMap’s™ output informs clinical management by providing the physician with additional information for evaluation and potential treatment.
“Our technology is designed to be non-invasive, rapid, and optimized for the clinical workflow. I believe that the combination of these attributes will be an important and a unique contribution to the care for patients suffering from cardiac arrhythmias.”
— CEO Mike Monko
vMap™ is covered by one or more US Patents: 10,319,144; 10,556,113; 10,595,736; 10,617,314; 10,709,347; 10,713,791; 10,856,816; 10,860,754. Additional US and international patents pending.